Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 3. Отображено 3.
25-03-2021 дата публикации

ENHANCEMENT OF PATHOGEN IMMUNOGENICITY

Номер: US20210085809A1

The present invention relates to a vaccine composition for use in in vivo administration, comprising a (attenuated) pathogen or commensal modified to be a pre-targeting vector, the pre-targeting vector comprising one or more pendent reactive moieties able to form a high affinity interaction with a complementary moiety residing on an immunogenic conjugate component. 1. A two component vaccine composition for use in in vivo administration , comprising a (preferably attenuated) pathogen or commensal modified as a pre-targeting vector , the pre-targeting vector comprising one or more pendent reactive moieties able to form a high affinity interaction with a complementary conjugate moiety residing on an immunogenic secondary component.2. A The composition of claim 1 , wherein the high affinity interaction comprises a supramolecular vector-conjugate interaction in an inclusion affinity complex.3. The composition of claim 1 , wherein a primary moiety on the vector surface is selected from the group consisting of streptavidin claim 1 , cyclodextrin claim 1 , antibodies claim 1 , antibody fragments claim 1 , ligands and aptamers claim 1 , and wherein the conjugate moiety is a moiety complementary to the respective vector moiety.4. The composition of claim 3 , wherein the vector moiety comprises adamantane groups claim 3 , and wherein the conjugate moiety includes cyclodextrin groups.5. The composition of claim 1 , wherein the high affinity interaction comprises formation of one or more covalent bonds.6. The composition of claim 5 , wherein the pathogen or commensal is functionalised to form a covalent click connection with a conjugate moiety claim 5 , preferably using copper-free click chemistry.7. The composition of claim 5 , wherein the vector moiety comprises one or more azide groups claim 5 , and wherein the conjugate moiety linked to the pathogen comprises one or more reactive alkyne groups claim 5 , preferably wherein both groups are suited for copper-free click ...

Подробнее
20-06-2024 дата публикации

Multiplexing targeting and imaging agents

Номер: WO2024126533A1

Provided herein are compounds of formula (I), formula (II) and formula (III) that are useful in the targeting and/or imaging of biological specimens, in particular as agents that may be used for targeting and imaging the hepatobiliary system and related cells. The compounds represent multiplexing tracers comprising a fluorescent dye-based targeting moiety and a secondary moiety that may include a second imaging label and/or a therapeutic agent.

Подробнее
17-06-2024 дата публикации

Multiplexing targeting and imaging agents

Номер: NL2033714B1
Принадлежит: Academisch Ziekenhuis Leiden

Provided herein are compounds of formula | and formula ll that are useful in the targeting and/or imaging of biological specimens, in particular as agents that may be used for targeting and 5 imaging the hepatobiliary system and related cells. The compounds represent multiplexing tracers comprising a fluorescent dye-based targeting moiety and a secondary moiety that may include a second imaging label and/or a therapeutic agent. R1 R2 R4 R3 R7 R10 R5 R8 Re R6 / N [ÎICB L I R11 R12 (I) R1 R2 R4 Ra R7 R8 RQ R10 R5 Re / N @ |/ | N X n R14 R14 (ll) 10

Подробнее